Fine Foods & Pharmaceuticals N.T.M. S.p.A.

DB:9S5 Stock Report

Market Cap: €182.1m

Fine Foods & Pharmaceuticals N.T.M Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Marco Francesco Eigenmann

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenureno data
Board average tenureless than a year

Recent management updates

Recent updates

CEO

Marco Francesco Eigenmann

no data

Tenure

Mr. Marco Francesco Eigenmann serves as President, Chief Executive Officer and Director at Fine Foods & Pharmaceuticals N.T.M. S.p.A. and served as its President of the Board of Directors. From 1987 to 199...

Board Members

NamePositionTenureCompensationOwnership
Marco Francesco Eigenmann
Presidentno datano datano data
Pietro Oriani
CEO & Directorless than a yearno datano data
Adriano Pala Ciurlo
Non Executive Directorno datano datano data
Deborah Venturini
Independent Directorless than a yearno datano data
Marco Costaguta
Non Executive Directorno datano datano data
Massimo Pretelli
Member of Board of statutory auditorsless than a yearno datano data
Guido Croci
Chairman of the Board of Statutory Auditorsless than a yearno datano data
Paolo Ferrario
Independent Directorless than a yearno datano data
Susanna Pedretti
Independent Director3.7yrsno datano data
Ada Imperadore
Independent Director3.7yrsno datano data
Giovanni Eigenmann
Non Executive Directorless than a yearno datano data
Elena Sacco
Non Executive Directorless than a yearno datano data

0.6yrs

Average Tenure

65yo

Average Age

Experienced Board: 9S5's board of directors are not considered experienced ( 0.6 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/25 17:10
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Fine Foods & Pharmaceuticals N.T.M. S.p.A. is covered by 5 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Gian GadiniBanca Akros S.p.A. (ESN)
Gianmarco BonacinaBanca Akros S.p.A. (ESN)
Andrea RandoneIntermonte SIM S.p.A.